# Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors

> **NCT04875871** · NA · TERMINATED · sponsor: **EBG MedAustron GmbH** · enrollment: 13 (actual)

## Conditions studied

- Cancer

## Interventions

- **RADIATION:** Particle radiotherapy
- **DIAGNOSTIC_TEST:** Magnetic resonance imaging
- **DIAGNOSTIC_TEST:** Computertomography
- **DIAGNOSTIC_TEST:** Copper-64-Diacetyl-bis (N4-methylthiosemicarbazone) Positron Emission Tomography-Computer Tomography (64Cu-ATSM-PET-CT)
- **DIAGNOSTIC_TEST:** 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)
- **DIAGNOSTIC_TEST:** Blood sampling

## Key facts

- **NCT ID:** NCT04875871
- **Lead sponsor:** EBG MedAustron GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-11
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-03-14
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** targeted patient enrollment was not met.
- **Last updated:** 2025-05-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04875871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04875871, "Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04875871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*